Cost-effectiveness of diagnosis of high blood pressure in primary care

The Lancet

Volumn 379, Issue 9817, 2012, Pages 709-710

  Wald, David S ^a   Simmonds, Mark C ^a   Morris, Joan K ^a   Rothwell, Peter M ^b   Wald, Nicholas J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; FALSE POSITIVE RESULT; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING; STROKE;

EID: 84857614210     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60302-X     Document Type: Letter

References (5)

1. K Lovibond, S Jowett, P Barton et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study Lancet 378 2011 1219 1230
2. MR Law, JK Morris, NJ Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
3. PM Rothwell, SC Howard, E Dolan et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Lancet 375 2010 895 905
4. M Law, N Wald, J Morris Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy Health Technol Assess 7 2003 31
5. NJ Wald, M Simmonds, JK Morris Screening for future cardiovascular disease using age alone compared with multiple risk factors and age PLoS One 6 2011 e18742